| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 07/27/2011 | CN102137849A Cyclic polyamines for binding phosphatidylserine |
| 07/27/2011 | CN102137837A PAI-1 inhibitor |
| 07/26/2011 | CA2463615C Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/21/2011 | US20110178294 Novel carboxylic acid derivatives, their preparation and use |
| 07/21/2011 | US20110177002 Cylic polyamines for binding phosphatidylserine |
| 07/21/2011 | DE102009053171B4 Verfahren zur Herstellung des Calcium-Komplexes von Dihydroxy-hydroxy-methylpropyl-tetraazacyclododecan-triessigsäure (Calcobutrol) Process for the preparation of the calcium complex of dihydroxy-hydroxy-methylpropyl-tetraazacyclododecane-triacetic acid (Calcobutrol) |
| 07/20/2011 | EP2345640A1 Adamantyl- acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/20/2011 | CN102131773A Methods for producing paricalcitol |
| 07/20/2011 | CN101544614B Phosphodiesterase III inhibitor, method for preparing same and medicinal application thereof |
| 07/20/2011 | CN101362728B Valsartan synthesis method |
| 07/19/2011 | US7982047 Derivatives of 1,3-diones having a herbicidal activity |
| 07/19/2011 | CA2472713C N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 07/19/2011 | CA2380920C Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 07/14/2011 | US20110172435 Treatment Of Inflammatory Bowel Disease |
| 07/12/2011 | US7977387 Aminobenzophenone compounds |
| 07/12/2011 | CA2481767C Severe sepsis preventive therapeutic agent |
| 07/07/2011 | WO2011082245A2 Metalloenzyme inhibitor compounds |
| 07/07/2011 | US20110166138 Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase for Modulation of Cannabinoid Receptors |
| 07/07/2011 | CA2785898A1 Metalloenzyme inhibitor compounds |
| 07/06/2011 | EP2341044A1 Cycloalkylamine derivative |
| 07/06/2011 | EP2340020A1 Manganese and cobalt complexes, their preparation and use |
| 07/06/2011 | CN1867554B Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors |
| 07/05/2011 | US7973061 Anaplastic lymphoma kinase modulators and methods of use |
| 07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/30/2011 | WO2011079291A1 Radiopharmaceutical complexes |
| 06/30/2011 | US20110160165 7-Pyrazolyl Tetracycline Compounds and Methods of Use Thereof |
| 06/30/2011 | DE102010024728A1 Bis-Tetrazolytriazenat, Verfahren zu dessen Herstellung und Sprengstoff oder Brennstoff enthaltend bis-Tetrazolytriazenat Up-Tetrazolytriazenat, process for its preparation and containing explosives or fuel-up Tetrazolytriazenat |
| 06/29/2011 | EP2338886A2 Naphthalene derivatives |
| 06/29/2011 | EP2338863A2 Bis-tetrazolytriazenate, method for producing same and explosive or fuel containing bis-tetrazolyltriazenate |
| 06/28/2011 | US7968601 Treating excess cortisol formation; obesity, cardiovascular disorders, glaucoma, osteoporosis, Alzheimer's Disease; antidiabetic agents |
| 06/28/2011 | US7968547 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/28/2011 | CA2645291C Dibenzyl amine derivatives as cetp inhibitors |
| 06/28/2011 | CA2635196C Glucocorticoid receptor modulators |
| 06/23/2011 | US20110152295 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 06/22/2011 | EP2334640A2 Methods for producing paricalcitol |
| 06/22/2011 | CN101498002B Surface-treating method for metal, treated metal surface and printed wiring substrate |
| 06/21/2011 | USRE42477 Carboxylic acid derivatives, their preparation and use |
| 06/21/2011 | US7964737 Process for producing 2-(n-butyl)-3-[[2′-(tetrazol-5-yl)biphenyl-4-yl]methyl]-1,3-diazaspiro[4.4] non-1-en-4-one |
| 06/21/2011 | US7964625 Antibiotics comprising bis(1-aryl-5-tetrazoly1)methane derivatives |
| 06/21/2011 | CA2396796C Stabilized medicinal aerosol particulate formulations |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2331514A2 Cyclic polyamines for binding phosphatidylserine |
| 06/15/2011 | CN102093302A Valsartan compound and new manufacturing method thereof |
| 06/15/2011 | CN102093301A Solvothermal synthesis method of sartanbiphenyltetrazole |
| 06/15/2011 | CN101591304B Compound containing tetrazolyl groups and polymers thereof |
| 06/15/2011 | CN101381381B Detection chromogenic reagent and reagent paper containing nitrile compounds |
| 06/14/2011 | USRE42462 Carboxylic acid derivatives, their preparation and use |
| 06/14/2011 | CA2489611C Processes for producing epoxytriazole derivative and intermediate therefor |
| 06/14/2011 | CA2425311C Ketone compounds and compositions for cholesterol management and related uses |
| 06/09/2011 | US20110137000 Method for preparing polymer materials doped with metal elements and resulting materials |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | DE102009057274A1 Making gadobutrol, to diagnose stroke, comprises e.g. reacting N-(6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl)-tetraaza-cyclododecane lithium chloride or bromide complex with haloacetic acid and lithium hydroxide or N-methyl imidazole |
| 06/08/2011 | CN101531671B Micro-porous copper coordination polymer, preparation method and application thereof |
| 06/08/2011 | CN101190916B Anticancer compound, preparation method and use thereof, and composition containing the compound |
| 06/07/2011 | CA2213759C Method for treating amyloidosis |
| 06/02/2011 | US20110130432 Heterocyclic Carboxamides For Use As Thrombin Inhibitors |
| 06/02/2011 | US20110129425 Process for preparing a pharmaceutical formulation of contrast agents |
| 06/01/2011 | EP2327690A1 Tricyclic compound |
| 06/01/2011 | EP1379510B1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chemosensitizers |
| 06/01/2011 | CN101189221B Ampa receptor potentiators |
| 05/26/2011 | WO2011061996A1 Process for production of biphenyl derivative |
| 05/26/2011 | WO2011061271A1 Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors |
| 05/26/2011 | US20110124695 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
| 05/26/2011 | CA2780840A1 Iodine-labeled homoglutamic acid and glutamic acid derivatives |
| 05/26/2011 | CA2780150A1 Substituted carbamoylmethylamino acetic acid derivatives as novel nep inhibitors |
| 05/25/2011 | EP2324009A1 Process for preparing certain cinnamide compounds |
| 05/25/2011 | CN1578663B Inhibitors of histone deacetylase |
| 05/25/2011 | CN102070546A Preparation method of 1-(2-ethoxyl)-5-mercapto tetrazole |
| 05/24/2011 | US7947842 Hydrates of alkaline-earth salts of irbesartan and the preparation thereof |
| 05/24/2011 | US7947838 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging |
| 05/24/2011 | US7947664 Angiotensin II receptor antagonists |
| 05/19/2011 | US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases |
| 05/18/2011 | EP2322514A1 Homoglutamic acid and glutamic acid derivatives |
| 05/18/2011 | CN1863795B P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same |
| 05/18/2011 | CN1727340B Temozolomide 8-carboxylic ester, and combination |
| 05/18/2011 | CN102060798A Method for synthesizing 2-(1-hydro-4-tetrazole)-4'-methylbiphenyl and derivatives thereof |
| 05/18/2011 | CN102060797A High-purity valsartanmethyl ester crystal production process |
| 05/17/2011 | US7943788 Glucopyranoside compound |
| 05/17/2011 | US7943780 Process for the preparation of candesartan cilexetil |
| 05/17/2011 | US7943778 Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives |
| 05/17/2011 | US7943648 Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same |
| 05/17/2011 | US7943647 Process for the preparation of tetrazole derivatives from organo aluminium azides |
| 05/12/2011 | WO2011054827A1 Process for the preparation of calcobutrol |
| 05/12/2011 | WO2011054480A1 Gadobutrol production by means of a ceramic membrane |
| 05/12/2011 | US20110111467 Method for Preparation of Carbamic Acid (R)-1-Aryl-2-Tetrazolyl-Ethyl Ester |
| 05/12/2011 | CA2777314A1 Process for the preparation of calcobutrol |
| 05/11/2011 | EP2318374A2 Insecticidal benzenedicarboxamide derivative |
| 05/11/2011 | CN101475540B Preparation of Valsartan |
| 05/05/2011 | WO2011051213A1 Process for the manufacture of organic compounds |
| 05/05/2011 | US20110105763 Process for Preparing Valsartan |
| 05/05/2011 | US20110105539 2'-halobiphenyl-4-yl intermediates in the synthesis of angiotensin ii antagonists |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | DE102009053171A1 Verfahren zur Herstellung des Calcium-Komplexes von Dihydroxy-hydroxy-methylpropyl-tetraazacyclododecan-triessigsäure (Calcobutrol) Process for the preparation of the calcium complex of dihydroxy-hydroxy-methylpropyl-tetraazacyclododecane-triacetic acid (Calcobutrol) |
| 05/05/2011 | CA2777031A1 Process for the manufacture of organic compounds |
| 05/04/2011 | EP2316821A1 Process for the manufacture of organic compounds |
| 05/04/2011 | CN102046575A Therapeutic agent for alzheimer's disease |
| 05/03/2011 | CA2582734C Dimeric small molecule potentiators of apoptosis |
| 05/03/2011 | CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers |
| 04/28/2011 | US20110094043 Method of synthesis of tetradentate amide macrocycle ligand and its metal-complex |